tert-Butyl 6-hydroxy-1-azaspiro[3.3]heptane-1-carboxylate

Catalog No.: 
ACUHQT085
CAS No.: 
1363381-56-9
Molecular Formula: 
C11H19NO3
Molecular Weight: 
213.28
tert-Butyl 6-hydroxy-1-azaspiro[3.3]heptane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$116.00In stockIn stock
250mg97%$218.00In stockIn stock
1g97%$418.00In stockInquiry
5g97%$1623.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 6-hydroxy-1-azaspiro[3.3]heptane-1-carboxylate
IUPAC Nametert-butyl 6-hydroxy-1-azaspiro[3.3]heptane-1-carboxylate
MDL No.MFCD22415220
Molecular FormulaC11H19NO3
Molecular Weight213.28
SMILESOC(C1)CC21CCN2C(OC(C)(C)C)=O
InChI KeyZWWHBQKHQHYPPF-UHFFFAOYSA-N
Synonym1363381-56-9 | 1389264-27-0 | 1-BOC-6-HYDROXY-1-AZASPIRO[3.3]HEPTANE | 1419101-19-1 | tert-Butyl 6-hydroxy-1-azaspiro[3.3]heptane-1-carboxylate | tert-butyl trans-6-hydroxy-1-azaspiro[3.3]heptane-1-carboxylate | tert-butyl cis-6-hydroxy-1-azaspiro[3.3]heptane-1-carbo
CAS No.1363381-56-9
PubChem CID72207992

Synthetic Route by SureRoute

1. ACUHQT085 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRMNG579 route compound structure diagram
    ACRMNG5791363380-93-1In Stock
  2. Then
  3. ACUHQT085 route product structure diagram
    ACUHQT0851363381-56-9In Stock
Inquiry

2. ACUHQT085 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUHQT085 route product structure diagram
    ACUHQT0851363381-56-9In Stock
Inquiry

3. ACUHQT085 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUHQT085 route product structure diagram
    ACUHQT0851363381-56-9In Stock
Inquiry

Comments (0)